Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Connect Biopharma Holdings Limited CNTB

Set alert

Price alert · CNTB

All alert types
0.80 USD -0.03 -3.97%

At close

0.85 +0.05 +5.96%

Pre-market · Nov 2, 5:21 AM ET

Bid
0.79 × 2
Ask
0.80 × 2
0.7805 Day range 0.8749
0.732 52-week range 3.82
YTD
-71.55%
1 year
-48.25%
Open
0.827
Prev close
0.8354
Mkt cap
50.52M
Vol
2.50M
Avg vol
3.99M
EPS
-1.19
P/E
0.00
Div yield
0.00%
More statistics
Low
0.7805
High
0.8749
Forward P/E
-5.04
Beta
-0.31
Short ratio
1.93
Inst. own
44.43%
Dividend
0.00
Ex-div date
Earnings
Mar 30, 2023
50-d avg
1.12
200-d avg
1.34
1y target
7.00

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for CNTB has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

-15.55 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C+2 / 5 overall

  • DCF 4
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 4
  • P/E 1
  • P/B 1

Valuation

P/E -2.8×
FY 2018: 0.0×FY 2019: -6.1×FY 2020: -1.3×FY 2021: -0.2×FY 2022: -0.1×FY 2023: -1.1×FY 2024: -4.9×FY 2025: -2.8×
FY 2018 5y median -1.1× FY 2025
P/S 2453×
FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 2.9×FY 2025: 2453×
FY 2018 5y median 0.0× FY 2025
P/B 3.7×
FY 2018: 0.0×FY 2019: -167×FY 2020: -41.5×FY 2021: 1.0×FY 2022: 0.3×FY 2023: 0.6×FY 2024: 0.8×FY 2025: 3.7×
FY 2018 5y median 0.8× FY 2025
P/FCF -3.0×
FY 2018: 0.0×FY 2019: -77.9×FY 2020: -35.7×FY 2021: -2.9×FY 2022: -0.5×FY 2023: -1.3×FY 2024: -3.1×FY 2025: -3.0×
FY 2018 5y median -2.9× FY 2025
EV/EBITDA -2.2×
FY 2018: 0.0×FY 2019: -41.4×FY 2020: -8.2×FY 2021: -0.0×FY 2022: 0.3×FY 2023: 0.7×FY 2024: 0.1×FY 2025: -2.2×
FY 2018 5y median 0.1× FY 2025
EV/Sales 1864×
FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: -0.1×FY 2025: 1864×
FY 2018 5y median 0.0× FY 2025
FCF Yield -32.9%
FY 2018: 0.0%FY 2019: -1.3%FY 2020: -2.8%FY 2021: -34.6%FY 2022: -216.7%FY 2023: -74.2%FY 2024: -32.0%FY 2025: -32.9%
FY 2018 5y median -34.6% FY 2025

Profitability

Gross Margin 100.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 100.0%FY 2025: 100.0%
FY 2018 5y median 0.0% FY 2025
Operating Margin -90740.6%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: -86.2%FY 2025: -90740.6%
FY 2018 5y median 0.0% FY 2025
Net Margin -86687.5%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: -60.0%FY 2025: -86687.5%
FY 2018 5y median 0.0% FY 2025
ROE -132.2%
FY 2018: 0.0%FY 2019: 395.5%FY 2020: 496.7%FY 2021: -74.3%FY 2022: -75.0%FY 2023: -61.2%FY 2024: -17.0%FY 2025: -132.2%
FY 2018 5y median -74.3% FY 2025
ROIC -135.7%
FY 2018: 0.0%FY 2019: -223.2%FY 2020: -123.3%FY 2021: -35.9%FY 2022: -75.2%FY 2023: -67.5%FY 2024: -24.1%FY 2025: -135.7%
FY 2018 5y median -67.5% FY 2025
ROA -98.9%
FY 2018: 0.0%FY 2019: -316.7%FY 2020: -469.3%FY 2021: -69.5%FY 2022: -67.9%FY 2023: -48.8%FY 2024: -15.4%FY 2025: -98.9%
FY 2018 5y median -67.9% FY 2025

Growth (YoY)

Revenue -99.8%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: -99.8%
FY 2018 FY 2025
Operating Income -158.7%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: -89.4%FY 2021: -223.8%FY 2022: -21.6%FY 2023: 42.1%FY 2024: 67.5%FY 2025: -158.7%
FY 2018 FY 2025
EPS (diluted) -257.1%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: -378.5%FY 2021: -73.0%FY 2022: 42.0%FY 2023: 92.6%FY 2024: 74.1%FY 2025: -257.1%
FY 2018 FY 2025
Free Cash Flow -112.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: -111.0%FY 2021: -232.8%FY 2022: -11.3%FY 2023: 53.4%FY 2024: 49.5%FY 2025: -112.0%
FY 2018 FY 2025

Financial Health

Current Ratio 3.7×
FY 2018: 70.4×FY 2019: 13.2×FY 2020: 27.8×FY 2021: 15.3×FY 2022: 10.0×FY 2023: 4.8×FY 2024: 11.5×FY 2025: 3.7×
FY 2018 5y median 10.0× FY 2025
Quick Ratio 3.7×
FY 2018: 70.4×FY 2019: 13.2×FY 2020: 27.8×FY 2021: 15.3×FY 2022: 10.0×FY 2023: 4.8×FY 2024: 11.5×FY 2025: 3.7×
FY 2018 5y median 10.0× FY 2025
Debt / Equity 0.0×
FY 2018: -4.5×FY 2019: -0.0×FY 2020: -0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2018 5y median 0.0× FY 2025
Net Debt / EBITDA 0.7×
FY 2018: 0.0×FY 2019: 0.3×FY 2020: 0.2×FY 2021: 1.3×FY 2022: 0.7×FY 2023: 1.7×FY 2024: 5.3×FY 2025: 0.7×
FY 2018 5y median 1.3× FY 2025
Interest Coverage 0.0×
FY 2018: 0.0×FY 2019: -2080×FY 2020: -4709×FY 2021: -14200×FY 2022: -5673×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2018 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2018 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2018 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31